Cargando…

Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

BACKGROUND: Circulating tumor cells (CTCs), an advantageous target of liquid biopsy, is an important biomarker for the prognosis and monitoring of cancer. Currently, detection techniques for CTCs are mainly based on the physical and/or epithelial characteristics of tumor cells. However, biofunctiona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jing, Cao, Shunwang, Situ, Bo, Zhong, Juan, Hu, Yanwei, Li, Shufen, Huang, Jinlan, Xu, Jiasen, Wu, Shiyang, Lin, Jinduan, Zhao, Qianwen, Cai, Zhen, Zheng, Lei, Wang, Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025832/ https://www.ncbi.nlm.nih.gov/pubmed/29954422 http://dx.doi.org/10.1186/s13046-018-0789-0

Ejemplares similares

Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer
por: Chen, Jing, et al.
Publicado: (2020)

Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma
por: Lin, Jinduan, et al.
Publicado: (2018)

Metabolic reprogramming in prostate cancer
por: Ahmad, Fahim, et al.
Publicado: (2021)

Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
por: Xu, Huan, et al.
Publicado: (2021)

Metabolic reprogramming in macrophage responses
por: Liu, Yang, et al.
Publicado: (2021)

Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Metabolic Reprogramming by Malat1 Depletion in Prostate Cancer
por: Nanni, Simona, et al.
Publicado: (2020)

Effect of PTEN loss on metabolic reprogramming in prostate cancer cells
por: Zhou, Xin, et al.
Publicado: (2019)

Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer
por: Sikander, Mohammed, et al.
Publicado: (2019)

SOX2 Mediates Metabolic Reprogramming of Prostate Cancer Cells
por: de Wet, Larischa, et al.
Publicado: (2022)

Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
por: Wu, Shiyang, et al.
Publicado: (2015)

Identification and Single‐Cell Analysis of Viable Circulating Tumor Cells by a Mitochondrion‐Specific AIE Bioprobe
por: Situ, Bo, et al.
Publicado: (2020)

Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer
por: Chetta, Paolo, et al.
Publicado: (2021)

Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics
por: Chianese, Ugo, et al.
Publicado: (2022)

Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis
por: Yang, Yi-Fang, et al.
Publicado: (2022)

Metabolic reprogramming of pulmonary fibrosis
por: Li, Jiaxin, et al.
Publicado: (2022)

Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer
por: Zecchini, Vincent, et al.
Publicado: (2014)

Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
por: Li, Xiaoran, et al.
Publicado: (2017)

Comprehensive Analysis of the Relationship Between Metabolic Reprogramming and Immune Function in Prostate Cancer
por: Xie, Weijie, et al.
Publicado: (2021)

Metabolic Reprogramming of Castration-Resistant Prostate Cancer Cells as a Response to Chemotherapy
por: Petrella, Greta, et al.
Publicado: (2022)

Efficient Feeder-Free Episomal Reprogramming with Small Molecules
por: Yu, Junying, et al.
Publicado: (2011)

Dynamic enhancer transcription associates with reprogramming of immune genes during pattern triggered immunity in Arabidopsis
por: Zhang, Ying, et al.
Publicado: (2022)

Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A
por: Whitlock, Nichelle C., et al.
Publicado: (2022)

Metabolic reprogramming in cancer: Mechanisms and therapeutics
por: Nong, Shiqi, et al.
Publicado: (2023)

Metabolic Reprogramming in Glioma
por: Strickland, Marie, et al.
Publicado: (2017)

KSHV Reprogramming of Host Energy Metabolism for Pathogenesis
por: Liu, Xiaoqing, et al.
Publicado: (2021)

Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism
por: Itkonen, Harri M., et al.
Publicado: (2016)

THEM6‐mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer
por: Blomme, Arnaud, et al.
Publicado: (2022)

Carbon Ion Radiotherapy Evokes a Metabolic Reprogramming and Individualized Response in Prostate Cancer
por: Ning, Renli, et al.
Publicado: (2021)

SQLE Mediates Metabolic Reprogramming to Promote LN Metastasis in Castration-Resistant Prostate Cancer
por: Xu, Zhenzhou, et al.
Publicado: (2021)

Recent Metabolomics Analysis in Tumor Metabolism Reprogramming
por: Han, Jingjing, et al.
Publicado: (2021)

Isolation and characterization of circulating tumor cells in prostate cancer
por: Diamond, Elan, et al.
Publicado: (2012)

PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence
por: Li, Yaqing, et al.
Publicado: (2016)

Immune cell metabolism and metabolic reprogramming
por: Hu, Chenchen, et al.
Publicado: (2022)

Chinese Herbs Interfering with Cancer Reprogramming Metabolism
por: Zhong, Zhangfeng, et al.
Publicado: (2016)

Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review
por: Cui, Meng-Ying, et al.
Publicado: (2022)

METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression
por: Wei, Wei, et al.
Publicado: (2023)

Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease
por: Wang, Mengdi, et al.
Publicado: (2022)

Metabolic Reprogramming and Predominance of Solute Carrier Genes during Acquired Enzalutamide Resistance in Prostate Cancer
por: Verma, Shiv, et al.
Publicado: (2020)

Gene Expression Analysis Reveals Prognostic Biomarkers of the Tyrosine Metabolism Reprogramming Pathway for Prostate Cancer
por: Li, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p6odssscef2e0htj9tnmhs3mkr